Predicting type 2 diabetes mellitus using haemoglobin A1c: A community-based historic cohort study

References

• Bonora E, Kiechl S, Mayr A, Zoppini G, Targher G, Bonadonna RC, et al. High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. Diabetes Care 2011;34:1038–40.
   PubMed Web of Science ®Google Scholar
• Colagiuri S, Borch-Johnsen K. DETECT-2: Early detection of type 2 diabetes and IGT. Diabetes Voice 2003;48:11–3.
   Google Scholar
• Sabanayagam C, Liew G, Tai ES, Shankar A, Lim SC, Subramaniam T, et al. Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia 2009;52:1279–89.
   PubMed Web of Science ®Google Scholar
• Lu ZX, Walker KZ, O’Dea K, Sikaris KA, Shaw JE. HbA1c for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010;33:817–9.
   Google Scholar
• International Expert Committee. International expert committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med. 2007;120:720–27.
   PubMed Web of Science ®Google Scholar
• Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, et al. Use of HbA1c in predicting progression to diabetes in French men and women: Data from an epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care 2006;29: 1619–25.
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010;33Suppl 1:S11–61.
   PubMed Web of Science ®Google Scholar
• Report of a World Health Organization Consultation, Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract. 2011;93:312–3.
   Google Scholar
• Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and Hba (1c): Analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care 2002;25:275–8.
   PubMed Web of Science ®Google Scholar
• S. Vinker, R. Yahalom, A. Elhayani. Long term intervention to reduce utilization of selected laboratory tests in the community. The 13th Annual Conference of the Israel Society of Quality in Medicine, Tel-Aviv, 2006.
   Google Scholar
• Manor O, Shmueli A, Ben-Yehuda A, Paltiel O, Calderon R, Jaffe DH. National Program for Quality Indicators in Community Healthcare in Israel Report, 2008–2010. School of Public Health and Community Medicine, Hebrew University-Hadassah. Jerusalem, Israel; 2012.
   Google Scholar
• Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M, Oizumi T, et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes?. Japan National Diabetes Survey. Diabetes Res Clin Pract. 2007; 76:251–6.
   PubMedGoogle Scholar
• Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factor. J Am Med Assoc. 2003;289:76–9.
   PubMed Web of Science ®Google Scholar
• Srikanth S, Deedwania P. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiol Clin. 2011;29:47–70.
   Google Scholar
• Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769–78.
   PubMed Web of Science ®Google Scholar
• Porath A, Rabinowitz G, Raskin-Segal A, Weitzman R, Ben-Said S. Quality indicators for community health care in Israel, 2005–2007 Public Report. Israel Ministry of Health, Israel National Institute for Health Policy and Health Services Research, 2008.
   Google Scholar
• Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: One-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 2010;33:2146–51.
   PubMed Web of Science ®Google Scholar
• Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 Year follow-up in the ADDITION Study, Denmark. Diabetologia 2008;51:249–57.
   Web of Science ®Google Scholar
• Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): A cluster-randomised controlled trial. Lancet 2012;380: 1741–8.
   PubMed Web of Science ®Google Scholar
• Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, et al. The Oregon experiment—effects of medicaid on clinical outcomes. N Engl J Med. 2013;368:1713–22.
   PubMed Web of Science ®Google Scholar
• Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med. 2011;124:395–401.
   PubMedGoogle Scholar
• Saltevo JT, Kautiainen H, Niskanen L, Oksa H, Puolijoki H, Sundvall J, et al. Ageing and associations of fasting plasma glucose and 2 h plasma glucose with HbA(1C) in apparently healthy population. ‘FIN-D2D’ study. Diabetes Res Clin Pract. 2011;93:344–9.
   Google Scholar
• Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–11.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36:(Suppl. 1)S11–S66.
   Google Scholar
• Kowall B, Rathmann W, Landgraf R. Is HbA1c a valid and feasible tool for the diagnosis of diabetes?. Diabetes Res Clin Pract. 2011;93:314–6.
   Web of Science ®Google Scholar
• Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res. 2007;39:677–82.
   PubMed Web of Science ®Google Scholar